These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35817636)

  • 1. Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants.
    El-Heneidy A; Cheung C; Lambert SB; Wang CYT; Whiley DM; Sly PD; Ware RS; Grimwood K
    Pathology; 2022 Dec; 54(7):928-934. PubMed ID: 35817636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants.
    Bucardo F; Reyes Y; Rönnelid Y; González F; Sharma S; Svensson L; Nordgren J
    Sci Rep; 2019 Jul; 9(1):10764. PubMed ID: 31341254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa.
    Magwira CA; Kgosana LP; Esona MD; Seheri ML
    Vaccine; 2020 Dec; 38(52):8260-8263. PubMed ID: 33213928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.
    Pollock L; Bennett A; Jere KC; Dube Q; Mandolo J; Bar-Zeev N; Heyderman RS; Cunliffe NA; Iturriza-Gomara M
    Clin Infect Dis; 2019 Sep; 69(8):1313-1319. PubMed ID: 30561537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent Rotavirus Vaccine and Wild-type Rotavirus Strain Shedding in Australian Infants: A Birth Cohort Study.
    Ye S; Whiley DM; Ware RS; Kirkwood CD; Lambert SB; Grimwood K
    Clin Infect Dis; 2018 Apr; 66(9):1411-1418. PubMed ID: 29149283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
    J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination.
    Middleton BF; Danchin M; Cunliffe NA; Jones MA; Boniface K; Kirkwood CD; Gallagher S; Kirkham LA; Granland C; McNeal M; Donato C; Bogdanovic-Sakran N; Handley A; Bines JE; Snelling TL
    Vaccine; 2023 Jun; 41(24):3579-3583. PubMed ID: 37179162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants.
    Burke RM; Payne DC; McNeal M; Conrey SC; Burrell AR; Mattison CP; Casey-Moore MC; Mijatovic-Rustempasic S; Gautam R; Esona MD; Thorman AW; Bowen MD; Parashar UD; Tate JE; Morrow AL; Staat MA
    J Infect Dis; 2024 Sep; 230(3):754-762. PubMed ID: 38330312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
    Donato CM; Handley A; Byars SG; Bogdanovic-Sakran N; Lyons EA; Watts E; Ong DS; Pavlic D; At Thobari J; Satria CD; Nirwati H; Soenarto Y; Bines JE
    J Infect Dis; 2024 Apr; 229(4):1010-1018. PubMed ID: 37592804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    Armah GE; Cortese MM; Dennis FE; Yu Y; Morrow AL; McNeal MM; Lewis KDC; Awuni DA; Armachie J; Parashar UD
    J Infect Dis; 2019 Feb; 219(5):746-749. PubMed ID: 30357332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children.
    Bucardo F; Nordgren J; Reyes Y; Gonzalez F; Sharma S; Svensson L
    Sci Rep; 2018 Jan; 8(1):1502. PubMed ID: 29367698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
    Markkula J; Hemming-Harlo M; Vesikari T
    Vaccine; 2020 Feb; 38(6):1378-1383. PubMed ID: 31862199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.
    Higashimoto Y; Ihira M; Miyazaki Y; Kuboshiki A; Yoshinaga S; Hiramatsu H; Suzuki R; Miyata M; Miura H; Komoto S; Yukitake J; Taniguchi K; Kawamura Y; Yoshikawa T
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
    Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM; Ali A
    J Infect Dis; 2017 Mar; 215(5):786-789. PubMed ID: 28329092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    Boniface K; Byars SG; Cowley D; Kirkwood CD; Bines JE
    J Infect Dis; 2020 Mar; 221(7):1070-1078. PubMed ID: 31763671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.
    Hsieh YC; Wu FT; Hsiung CA; Wu HS; Chang KY; Huang YC
    Vaccine; 2014 Feb; 32(10):1199-204. PubMed ID: 24076325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner.
    Nordgren J; Sharma S; Bucardo F; Nasir W; Günaydın G; Ouermi D; Nitiema LW; Becker-Dreps S; Simpore J; Hammarström L; Larson G; Svensson L
    Clin Infect Dis; 2014 Dec; 59(11):1567-73. PubMed ID: 25097083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix
    Chauwa A; Bosomprah S; Laban NM; Phiri B; Chibuye M; Chilyabanyama ON; Munsaka S; Simuyandi M; Mwape I; Mubanga C; Chobe MC; Chisenga C; Chilengi R
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus A shedding and HBGA host genetic susceptibility in a birth community-cohort, Rio de Janeiro, Brazil, 2014-2018.
    Cantelli CP; Velloso AJ; Assis RMS; Barros JJ; Mello FCDA; Cunha DCD; Brasil P; Nordgren J; Svensson L; Miagostovich MP; Leite JPG; Moraes MTB
    Sci Rep; 2020 Apr; 10(1):6965. PubMed ID: 32332841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histo-Blood Group Antigens in Children with Symptomatic Rotavirus Infection.
    Pérez-Ortín R; Vila-Vicent S; Carmona-Vicente N; Santiso-Bellón C; Rodríguez-Díaz J; Buesa J
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30974776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.